Siemens Healthineers: Q3 profit down but outlook confirmed
BERLIN (Reuters) – German medical device maker Siemens Healthineers reported lower third-quarter profits on Wednesday as revenue from its rapid antigen tests for COVID-19 and the impact of pandemic-related lockdowns in China on production.
Net profit fell 8% year-on-year to 364 million euros, the company said. Analysts on average had expected an increase to 415 million euros, according to a consensus published on the Healthineers website.
Adjusted profit before interest and tax (Ebit) fell 19% to 765 million euros on revenue of 5.19 billion euros, against 5 billion euros a year earlier.
The company maintained its outlook for fiscal 2022 as supply chain headwinds and COVID-19-related lockdowns pushed back some sales to subsequent quarters.
“Supply chain headwinds and pandemic-related lockdowns pushed some sales back into subsequent quarters, and cost increases weighed on earnings,” CEO Bernd Montag said.
Siemens Healthineers said it expects like-for-like revenue growth of between 5.5% and 7.5% and adjusted basic earnings per share of between 2.25 euros and 2.35 euros.
(Written by Rachel More; French version Dina Kartit, editing by Kate Entringer)
It is always my pleasure to provide insightful information on important topics and if you have learned something from my article then I thank you for taking the time to share it with your friends or family.
We put a lot of heart and invest a lot of time trying to bring you the most interesting articles.
You would encourage us to do it even better in the future. Thank you!